Ruth Gimeno

Group Vice President, Diabetes, Obesity & Cardiometabolic Research and Early Clinical Development · Eli Lilly and Company · company speakers →

Is this you? Claim this profile →

No public contact links on file.

Speaking history

Fierce JPM Week

13 January 2026 San Francisco, United States “Fierce JPM Week 2026 Panel: GLP-1s and the Next Wave in Obesity Therapies”

Sourcing speakers for your event?

Browse the speaker directory →